XCMR Strengthens Leadership Team with Healthcare Systems Expert Dr. Katja Auer

XCMR is pleased to announce the appointment of Dr. Katja Auer as Chief of Staff. With nearly two decades of experience in the Ultraviolet-C (UV-C) industry, Dr. Auer brings a wealth of knowledge and expertise in pathogen reduction, applications engineering, regulatory affairs, quality management, education, and complex systems leadership.

XCMR Showcases UV Innovation at IUVA Americas Conference 2024

The International Ultraviolet Association (IUVA) Americas Conference 2024 was a hub of innovation, bringing together UV experts from around the world. The conference emphasized the growing potential of UV technology in tackling pressing global issues like clean water, safe food, and public health.

XCMR Showcases Next-Generation PPE at the ATS 2024 Respiratory Innovation Summit

The Respiratory Innovation Summit (RIS), hosted by the American Thoracic Society (ATS), serves as a crucial platform for fostering innovation in respiratory health. The ATS, the nation’s leading medical society dedicated to improving global respiratory health, organizes this annual summit to connect key stakeholders and accelerate the development of novel treatments for respiratory diseases.

XCMR Welcomes Dr. Ben Robertson, Senior Director of Test Method Development and Analytics

We are is pleased to announce that Dr. Ben Robertson has joined the team as senior director of Test Method Development and Analytics. Dr. Robertson is a highly accomplished biomedical engineer and scientist with 15 years of experience spanning defense, academia, biopharma, and medical devices.

XCMR Showcases Innovative UV-C Technology at ARPA-H BREATHE Proposer Day 2024

XCMR Co-founder and Chairman Kenneth Kelley presented the company’s innovative UV-C technology at the ARPA-H BREATHE Proposer Day, highlighting its potential to revolutionize respiratory protection.

2024 CWMD/MCDC Winter Medical & WMD Countermeasure Symposium

XCMR presented its innovative infection prevention platform, EMITR™, and next-generation PPE solutions at the CWMD/MCDC 2024 Winter Medical & WMD Countermeasure Symposium.

XCMR Secures $1.25M AFWERX Contract to Combat Surgical Site Infections

XCMR has been awarded a $1.25 million, 21-month Direct to Phase II Small Business Innovation Research (SBIR) contract from the U.S. Air Force Research Laboratory (AFRL), through its AFWERX program.

XCMR Demonstrates Next-Generation PPE at 2023 EPA International Decontamination Research and Development Conference

XCMR recently participated in the 2023 EPA International Decontamination Research and Development Conference, where Chris Bowers presented on the topic of “Next Generation Personal Protective Equipment for Real-time Inactivation of Airborne Biological Threats.”

XCMR Strengthens Financial Leadership with Appointment of Phil Heifetz as Senior Director of Finance

XCMR is pleased to announce the appointment of Phil Heifetz as senior director of finance. Phil brings over 25 years of experience in finance and business development across the life sciences, medical devices, and healthcare IT sectors.

Infectious Disease Expert Dr. Richard Martinello Joins XCMR Advisory Board

We are pleased to announce that Dr. Richard Martinello, a renowned infectious disease specialist, has joined our advisory board as chief medical advisor. Dr. Martinello’s extensive experience and expertise will be invaluable as we continue to develop innovative solutions to combat infectious diseases.

News